Related Experiment Video
Updated: Jul 26, 2026

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
Published on: June 29, 2015
[Advances in anti-thrombotic therapy]
1Servicio de Hematología, Clínica Universitaria, Universidad de Navarra, Pamplona, Avda Pío XII, 31008 Pamplona. japaramo@unav.es
Abstract:
Improved understanding of the mechanisms of thrombogenesis has led to the discovery of new antithrombotic agents, anticoagulants, antiplatelets and fibrinolytics. Although most of them are still under development, low molecular weight heparins, glycoprotein IIb/IIIa receptor antagonists, inhibitors of the ADP receptor of platelets and new fibrinolytics have already proved their efficacy in the clinical setting. Compounds are being developed that have the potential to prevent and treat thrombosis by modulating vessel wall function.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Venous Thrombosis III: Interprofessional Care

